Healthcare -
Biotechnology - NASDAQ - US
$ 111.1
-3.72 %
$ 5.47 B
Market Cap
-18.72
P/E
AXSM - REVENUE
Revenue AXSM - Axsome Therapeutics, Inc.
386 M
LAST VALUE
177.64%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR